Key result
APLN gene variants showed no significant association with serum apelin levels, type 2 diabetes, or metabolic parameters in a European population.
Observational (n=917)
Answers are grounded in this paper and cite their sources.
Common variants in the apelin gene do not appear to be associated with serum apelin levels or type 2 diabetes in a European population.
AIMS: Apelin is a peptide produced and secreted by white adipose tissue. It is synthesized as preproapelin, a protein containing 77 aminoacids which is then cleaved to shorter active fragments. As an adipokine, apelin plays a role in the regulation of many biological functions, including body energy homeostasis and glucose metabolism, water balance, and immunity. We have recently demonstrated that subjects with type 2 diabetes (T2D) have significantly higher serum apelin levels compared with controls, and that these levels associate with fasting glucose, basal disposition index, age, and diagnosis of T2D. The first aim of this study was to search for sequence variants in the apelin gene (APLN), located on chromosome Xq25-q26.1 that may associate with serum levels of apelin. The second aim was to analyze the possible association between diabetes and diabetes-related traits and APLN variants. METHODS: We designed a two-step genetic association study. Step one consisted of an initial screen of 100 individuals selected from the extremes of the apelin distribution levels wherein we sequenced the APLN gene to identify common variants. In step two, the rs181301686 with a minor allele frequency >0.2 was genotyped in 917 individuals to explore its association with T2D and diabetes-related traits. RESULTS: Five sequence variations were found across the APLN gene. To test for association with apelin levels, the rs181301686 and rs2281069 single-nucleotide polymorphisms were genotyped in 256 subjects for whom serum apelin levels were available. No significant differences were observed in apelin levels between genotypes. Association analysis in 917 individuals did not show significant differences between APLN genotypes and diabetes and diabetes-related traits. CONCLUSIONS: Resequencing of the apelin gene in subjects stratified by low or high apelin levels identified five APLN variants in an European population. No association was found between the most frequent variant, diabetes, and metabolic parameters.
No takes yet. Share an insight, caveat, or question.
Sentinelli et al. (2016) conducted an observational in Type 2 diabetes (n=917). APLN gene variants vs. Other APLN genotypes was evaluated on Serum apelin levels, diabetes, and diabetes-related traits. APLN gene variants showed no significant association with serum apelin levels, type 2 diabetes, or metabolic parameters in a European population.
Synapse has enriched 10 related papers. Consider them for comparative context: